These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9384255)
21. Antiestrogenic effect of opioid peptides in rat uterus. Oszter A; Vértes Z; Töröcsik B; Környei JL; Kovács KA; Vértes M J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):25-32. PubMed ID: 11074353 [TBL] [Abstract][Full Text] [Related]
22. The effect of 17-alpha-estradiol, a possible endogenous opiate antagonist, on D-ala2-met5-enkephalinamide-induced blood pressure responses in conscious, unrestrained rats. Chandra A; Dixon WR NIDA Res Monogr; 1986; 75():339-42. PubMed ID: 3123948 [TBL] [Abstract][Full Text] [Related]
24. The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism. Bergasa NV; Zhou J; Ravi J; Shi Q Peptides; 1999; 20(8):979-86. PubMed ID: 10503777 [TBL] [Abstract][Full Text] [Related]
25. Delta opioid agonists inhibit proliferation of highlypurified murine CD4+ and CD8+ T-cells. Shahabi NA; Sharp BM Adv Exp Med Biol; 1995; 373():29-36. PubMed ID: 7668157 [TBL] [Abstract][Full Text] [Related]
26. Mesencephalic sites of action of an enkephalin analogue (D-Met2, Pro5)-enkephalinamide and naloxone on the anterior pituitary of male rats. Molnár J; Halász B Brain Res; 1991 Nov; 563(1-2):270-2. PubMed ID: 1786539 [TBL] [Abstract][Full Text] [Related]
27. Effects of a stable enkephalin analogue, (D-Met2,Pro5)-enkephalinamide, and naloxone on cortical blood flow and cerebral blood volume in experimental brain ischemia in anesthetized cats. Sándor P; Gotoh F; Tomita M; Tanahashi N; Gogolak I J Cereb Blood Flow Metab; 1986 Oct; 6(5):553-8. PubMed ID: 3020070 [TBL] [Abstract][Full Text] [Related]
28. Potentiation of [D-ala2]enkephalinamide analgesia in rats by thiorphan. Chipkin RE; Latranyi MZ; Iorio LC; Barnett A Eur J Pharmacol; 1982 Sep; 83(3-4):283-8. PubMed ID: 6756941 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of opiate receptors in the dorsal pontine tegmentum inhibits reflex contraction of the urinary bladder. Willette RN; Morrison S; Sapru HN; Reis DJ J Pharmacol Exp Ther; 1988 Jan; 244(1):403-9. PubMed ID: 2891844 [TBL] [Abstract][Full Text] [Related]
30. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Hyder SM; Stancel GM; Chiappetta C; Murthy L; Boettger-Tong HL; Makela S Cancer Res; 1996 Sep; 56(17):3954-60. PubMed ID: 8752163 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide. Lembeck F; Donnerer J; Barthó L Eur J Pharmacol; 1982 Nov; 85(2):171-6. PubMed ID: 6185352 [TBL] [Abstract][Full Text] [Related]
32. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity. Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800 [TBL] [Abstract][Full Text] [Related]
33. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria. Wong-Dusting HK; Rand MJ Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945 [TBL] [Abstract][Full Text] [Related]
34. Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models. Ke HZ; Paralkar VM; Grasser WA; Crawford DT; Qi H; Simmons HA; Pirie CM; Chidsey-Frink KL; Owen TA; Smock SL; Chen HK; Jee WS; Cameron KO; Rosati RL; Brown TA; Dasilva-Jardine P; Thompson DD Endocrinology; 1998 Apr; 139(4):2068-76. PubMed ID: 9528995 [TBL] [Abstract][Full Text] [Related]
35. Opioid receptor-mediated inhibition of omega-conotoxin GVIA-sensitive calcium channel currents in rat intracardiac neurons. Adams DJ; Trequattrini C J Neurophysiol; 1998 Feb; 79(2):753-62. PubMed ID: 9463438 [TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Aronica SM; Katzenellenbogen BS Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263 [TBL] [Abstract][Full Text] [Related]
38. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus. Campen CA; Jordan VC; Gorski J Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316 [TBL] [Abstract][Full Text] [Related]
39. Effect of (D-Met2, Pro5)enkephalinamide, a highly potent opiate agonist, on the drinking behaviour of rats. Decsi L; Schmidt P Neuropharmacology; 1985 Jan; 24(1):5-8. PubMed ID: 2984598 [TBL] [Abstract][Full Text] [Related]
40. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus. Weihua Z; Ekman J; Almkvist A; Saji S; Wang L; Warner M; Gustafsson JA Biol Reprod; 2002 Aug; 67(2):616-23. PubMed ID: 12135905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]